Susquehanna Portfolio Strategies’s Astrana Health ASTH Stock Holding History
Bought
Maintained
Sold
Other funds holding ASTH
3C
SW
Susquehanna Portfolio Strategies's ASTH Position: Q4 2024 in Review
Susquehanna Portfolio Strategies sold out of Astrana Health (ASTH) in Q4 2024, closing a stake of 7,463 shares — an estimated $432K sold.
Susquehanna Portfolio Strategies first reported a position in ASTH in Q4 2023 and held it in 4 quarters. The position peaked at $432K in Q3 2024. 179 funds tracked by Wall St. Rank hold ASTH as of Q4 2024.
- Susquehanna Portfolio Strategies reported no remaining Astrana Health position as of Q4 2024 after selling out during the quarter.
- Susquehanna Portfolio Strategies sold 7,463 Astrana Health shares in Q4 2024, an estimated $432K.
- Susquehanna Portfolio Strategies first reported a position in Astrana Health in Q4 2023 and held it in 4 quarters.
- Susquehanna Portfolio Strategies's Astrana Health position peaked at $432K in Q3 2024.
- 179 funds tracked by Wall St. Rank held Astrana Health as of Q4 2024.
Based on Susquehanna Portfolio Strategies's 13F filing for Q4 2024, filed 14 Feb 2025.